Marine Drugs | |
Molecular Mechanisms by Which a |
|
Ulf Geisen1  Marion Zenthoefer5  Matthias Peipp6  Jannik Kerber1  Johannes Plenge4  Antonella Managò2  Markus Fuhrmann3  Roland Geyer3  Steffen Hennig5  Dieter Adam4  Levent Piker5  Gerald Rimbach7  Holger Kalthoff1  | |
[1] Division of Molecular Oncology, Institute for Experimental Cancer Research, Medical Faculty, CAU, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mails:;Department of Biology, University of Padua, 35131 Padua, Italy; E-Mail:;Numares AG, 93053 Regensburg, Germany; E-Mails:;Institute of Immunology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mails:;CRM, Coastal Research & Management, 24159 Kiel, Germany; E-Mails:;Division of Stem Cell Transplantation and Immunotherapy, Department of Internal Medicine II, University Hospital Schleswig-Holstein, 24105 Kiel, Germany; E-Mail:;Institute of Human Nutrition and Food Science, Christian-Albrechts University of Kiel, 24118 Kiel, Germany; E-Mail: | |
关键词:
algae;
|
|
DOI : 10.3390/md13074470 | |
来源: mdpi | |
【 摘 要 】
Pancreatic cancer is one of the most aggressive cancer entities, with an extremely poor 5-year survival rate. Therefore, novel therapeutic agents with specific modes of action are urgently needed. Marine organisms represent a promising source to identify new pharmacologically active substances. Secondary metabolites derived from marine algae are of particular interest. The present work describes cellular and molecular mechanisms induced by an HPLC-fractionated, hydrophilic extract derived from the Baltic brown seaweed
【 授权许可】
CC BY
© 2015 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190009484ZK.pdf | 3733KB | download |